Colorectal Cancer
Advertisement
Black people taking GLP-1RA have poor bowel preparation prior to colonoscopy, which can compromise diagnosis.
A total 9.8% of respondents commented about the effect of colon cancer on the Black community.
More research is warranted to identify barriers to successful colorectal cancer treatment across all races and ethnicities.
There exists significant health disparities with respect to people living in rural communities with GI cancers.
Screening guideline supported studies for colorectal cancer lack Black representation.
A new study shows significant racial disparities in colon polyp prevalence and risk.
A study analyzed gender diversity in leadership, funding, as well as authorship in US colon cancer clinical trials.
The incidence of early-onset colorectal cancer, specifically in Blacks, is attributed to several factors.
A study finds significant disparities in mortality rate by both sex and race among people with colon cancer in the US.
A study reported a steady increase in early-onset colorectal cancer cases.
Colorectal cancer screening uptake among privately insured individuals aged 45-49 years have increased significantly.
People of color had an average delay of 6 months from symptom onset to diagnosis of young-onset colorectal cancer.
Colorectal cancer patients with Medicaid or no insurance face significantly higher risks for surgery and other complications.
A recurrence-free survival period of 8 months is a crucial cutoff for early recurrence.
Researchers found that food antigens, particularly milk proteins, activate the intestinal immune system to suppress tumors.
A study found that metabolites from diets high in red and processed meat significantly increase the risk of young-onset CRC.
Laparoscopic colectomy in obese patients with locally advanced colon cancer offers comparable long-term outcomes to open surg
The study revealed that 17 of 34 cancers studied occurred more in younger people; the risk increases with each birth cohort.
those currently taking immunomodulators had approximately a 78% lower risk of CKD compared to those not on these medications
Dr. Craig Eagle talks about Shield blood-based Colorectal Cancer Test.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.